Endocyte Pops on Merck Deal - Presented by: The Aol. On Network

04/16/12 Endocyte shares posted a triple-digit percentage gain after entering into an agreement with Merck & Co. The development deal for Endocyte's experimental cancer drug could bring an additional $880 million to the biopharmaceutical company in m



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
YHOO $ 38.77 0.12 ▲ 0.31%
BAC $ 17.12 0.09 ▲ 0.53%
AAPL $ 101.845 0.79 ▲ 0.78%
AVAL $ 13.65 unch
BABA $ 87.60 2.29 ▼ 2.55%
RAD $ 5.14 0.03 ▲ 0.59%
SIRI $ 3.545 0.03 ▲ 0.71%
FB $ 77.0987 0.30 ▲ 0.39%

As of 9/23/2014, 10:46 AM
More Most Active